Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.
Genes and immunity, 24(6): 292-294 PMID 38082155 DOI 10.1038/s41435-023-00227-6
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.